Striverdi Respimat (Olodaterol) for COPD | MyCOPDTeam

Connect with others who understand.

sign up Log in
About MyCOPDTeam
Powered By


Striverdi Respimat is a prescription drug approved by the Food and Drug Administration (FDA) in 2014 for daily maintenance of bronchospasms in chronic obstructive pulmonary disease (COPD). Striverdi Respimat is not indicated for acute attacks. Striverdi Respimat is also known by its drug name, Olodaterol.

Striverdi Respimat is a bronchodilator, a drug that dilates the bronchi and bronchioles in the lungs, making it easier to breathe. Striverdi Respimat is believed to work by relaxing smooth muscles in the airways. Striverdi Respimat is considered a long-acting bronchodilator.

How do I take it?
Striverdi Respimat comes as an inhaler. Two sprays of Striverdi Respimat are inhaled orally once per day, at the same time each day. The effects of Striverdi Respimat last for 24 hours.

Side effects
Common side effects of Striverdi Respimat include cough, runny nose, cold symptoms, diarrhea, bronchitis, bladder infections, back and joint pain, dizziness, and rash.

Inform your doctor if you experience chest pain, fast or irregular heart rate (tachycardia), pneumonia symptoms, or worsening COPD symptoms, while taking Striverdi Respimat.

Many drugs can cause allergic reactions which, in the most serious cases, can result in death. Seek immediate medical help if you experience signs of a severe allergic reaction such as difficulty breathing or swelling of the face, throat, eyes, lips, or tongue.


Striverdi Respimat

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in